Initial Efficacy and Safety Results of Irinotecan Liposome Injection (nal-IRI) in Patients with Small Cell Lung Cancer
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Rodriguez, LPA
- Spigel, D
- Chen, Y
- Jove, M
- Rich, P
- Hayes, T
- Calderon, VG
- Bernabe, R
- Navarro, A
- Dowlati, A
- Zhang, B
- Moore, Y
- Wang, T
- Nazarenko, N
- Ponce, S
- Bunn, P
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Keywords
- Irinotecan Liposome Injection; Monotherapy; small cell lung cancer
Campos de Estudio
Cita
Rodriguez,L,Spigel,D,Chen,Y,Jove,M,Juan,O,Rich,P,Hayes,T et al. Initial Efficacy and Safety Results of Irinotecan Liposome Injection (nal-IRI) in Patients with Small Cell Lung Cancer. STE 800, 230 PARK AVE, NEW YORK, NY 10169:ELSEVIER SCIENCE INC. 2019 p.p. 211-212.
Portal de investigación